Company Comparison
KSQ Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | KSQ Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | Lagos, Nigeria |
| Founded | 2018 | 2019 |
| Status | Active | Active |
| Last Funding Stage | Series A | Series B |
| Total Funding | $63M | $45M |
| Valuation | — | — |
What They Build
KSQ Therapeutics
A biotechnology company developing cancer immunotherapies using CRISPR-based functional genomics to identify novel drug targets.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
KSQ Therapeutics
Sector Overlap
Both KSQ Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →